Reference
Do P, et al. Augmented ustekinumab dosing is needed to achieve clinical response in patients with anti-TNF refractory pediatric Crohn's disease: A retrospective chart review. F1000 Research 9: 316, Jan 2021. Available from: URL: http://f1000research.com/articles?tab=ALL&articleType=&subjectArea=&subtopic=&show=50
Rights and permissions
About this article
Cite this article
Anti-inflammatories. Reactions Weekly 1880, 41 (2021). https://doi.org/10.1007/s40278-021-04875-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40278-021-04875-0